About Index Trending news
Analyze
Top 50 Pricing
SAGE Therapeutics

SAGE Therapeutics

Work at SAGE Therapeutics? Add yourself to this profile

SAGE Therapeutics

SAGE Therapeutics develops and delivers novel medicines for most debilitating and disabling central nervous system disorders.

Elsewhere

Alexa global traffic share

Latest funding Show all
Venture capital (Series C)
$38,000,000
Foresite Capital, ARCH Venture Partners, OrbiMed Advisors, +2
Venture capital (Series B)
$20,000,000
Employees

Team size

10+
Locations
HQ
Xconomy

Caveats But No "Quicksand" In Sage's Positive Postpartum Trial Data

The Motley Fool

Here's Why Sage Therapeutics' Stock Is Falling Today

Health Stock markets